Cite
HARVARD Citation
Huber, C. et al. (n.d.). 571 ANV419 is a novel CD122-selective IL-2/anti-IL-2 antibody fusion protein with potent CD8 T cell and NK cell stimulatory function in vitro and in vivo. Journal for immunotherapy of cancer. p. A343. [Online].